Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 2.12% | $20.26M | CHF200.79B | 21.86% | 80 Outperform | |
| ASML Holding NV | 1.89% | $18.09M | €353.45B | 35.81% | 76 Outperform | |
| Roche Holding AG | 1.87% | $17.89M | CHF253.28B | 41.76% | 73 Outperform | |
| AstraZeneca | 1.86% | $17.74M | £208.42B | 29.34% | 80 Outperform | |
| Nestlé SA | 1.75% | $16.69M | CHF197.01B | 19.33% | 71 Outperform | |
| Unilever | 1.27% | $12.15M | £105.45B | -7.94% | 72 Outperform | |
| Shell (UK) | 1.21% | $11.58M | £153.44B | 9.76% | 73 Outperform | |
| SAP SE | 1.16% | $11.08M | €242.99B | -12.57% | 66 Neutral | |
| Zurich Insurance Group | 1.08% | $10.37M | CHF82.76B | 21.09% | 78 Outperform | |
| ― | 1.04% | $9.90M | ― | ― | ― |